Qianqian Guo, Dongshan Wu, Lei Gao, Yingjie Bai, Yuan Liu, Nianxin Guo, Xiaoxia Du, Jun Yang, Xiaoming Wang, and Xiaoguang Lei
ACS Catal. 2020, https://doi/10.1021/acscatal.0c01187
The β-lactam antibiotic resistance has become a critical global health threat. One of the major reasons for drug resistance is the expression of β-lactamases especially metallo-β-lactamases such as New Delhi metallo-β-lactamase (NDM-1) by Gram-negative bacteria. The fungal natural product aspergillomarasmine A (AMA) was found to be a promising inhibitor of NDM-1 to potentiate currently used β-lactam antibiotics to overcome drug resistance both in vitro and in vivo. Although several chemical synthesis and chemoenzymatic synthesis approaches to access AMA have been reported, the biosynthesis of AMA was still elusive. Herein, we identified the key enzyme responsible for the biosynthesis of AMA in Aspergillus oryzae. AMA synthase is a PLP-dependent cysteine synthase homologous protein which utilizes O-acetyl-Lserine/O-phospho-L-serine and L-aspartic acid as its substrates. Remarkably, this enzyme catalyzes two consecutive C-N bond formations to produce AMA efficiently which may be attributed to the spacious substrate-binding pocket. PLP is covalently bound to Lys61 by an internal aldimine from the PLP re face, and the si face of PLP pyridine ring is accessible to the substrates to promote the nucleophilic addition of amino acids to the double bond of the external adiminine and ultimately to generate chiral Cα with S configuration. The catalytic mechanism was proposed based on molecular docking and biochemical experiments. In addition, we have further investigated the substrate scope of AMA synthase and identified a variant enzyme which shows promising potential in producing structurally diverse molecules containing C-N bond.
Qianqian Guo, Dongshan Wu, Lei Gao, Yingjie Bai, Yuan Liu, Nianxin Guo, Xiaoxia Du, Jun Yang, Xiaoming Wang, and Xiaoguang Lei
ACS Catal. 2020, https://doi/10.1021/acscatal.0c01187
The β-lactam antibiotic resistance has become a critical global health threat. One of the major reasons for drug resistance is the expression of β-lactamases especially metallo-β-lactamases such as New Delhi metallo-β-lactamase (NDM-1) by Gram-negative bacteria. The fungal natural product aspergillomarasmine A (AMA) was found to be a promising inhibitor of NDM-1 to potentiate currently used β-lactam antibiotics to overcome drug resistance both in vitro and in vivo. Although several chemical synthesis and chemoenzymatic synthesis approaches to access AMA have been reported, the biosynthesis of AMA was still elusive. Herein, we identified the key enzyme responsible for the biosynthesis of AMA in Aspergillus oryzae. AMA synthase is a PLP-dependent cysteine synthase homologous protein which utilizes O-acetyl-Lserine/O-phospho-L-serine and L-aspartic acid as its substrates. Remarkably, this enzyme catalyzes two consecutive C-N bond formations to produce AMA efficiently which may be attributed to the spacious substrate-binding pocket. PLP is covalently bound to Lys61 by an internal aldimine from the PLP re face, and the si face of PLP pyridine ring is accessible to the substrates to promote the nucleophilic addition of amino acids to the double bond of the external adiminine and ultimately to generate chiral Cα with S configuration. The catalytic mechanism was proposed based on molecular docking and biochemical experiments. In addition, we have further investigated the substrate scope of AMA synthase and identified a variant enzyme which shows promising potential in producing structurally diverse molecules containing C-N bond.